Shilpa Medicare is currently trading at Rs. 613.00, up by 12.15 points or 2.02% from its previous closing of Rs. 600.85 on the BSE.
The scrip opened at Rs. 599.00 and has touched a high and low of Rs. 621.55 and Rs. 596.75 respectively. So far 21460 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 636.00 on 03-Oct-2016 and a 52 week low of Rs. 355.00 on 20-Jan-2016.
Last one week high and low of the scrip stood at Rs. 636.00 and Rs. 517.35 respectively. The current market cap of the company is Rs. 4664.67 crore.
The promoters holding in the company stood at 56.89%, while institutions and non-institutions held 27.32% and 15.79% respectively.
Shilpa Medicare has received an approval from the United States Food & Drug Administration (USFDA) for Azacitidine - Injection ANDA of SEZ Formulations Facility situated at Jadcherla, near Hyderabad.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.25 |
Dr. Reddys Lab | 6263.70 |
Cipla | 1406.25 |
Zydus Lifesciences | 948.20 |
Lupin | 1615.85 |
View more.. |